Ellington Financial Reports Estimated Book Value for February 2025
March 28, 2025 - 00:11
OLD GREENWICH, Conn., March 27, 2025 – Ellington Financial Inc. has disclosed its estimated book value per share of common stock, reporting a value of $13.39 as of February 28, 2025. This figure reflects the company's financial performance and includes the impact of a previously declared monthly dividend.
On March 25, 2025, a dividend of $0.13 per share was paid to shareholders who were on record as of February 28, 2025. The ex-dividend date coincided with this record date, allowing investors to benefit from the dividend payment.
The announcement of the estimated book value is an important indicator for investors, as it provides insight into the company's financial health and asset valuation. As the financial landscape continues to evolve, such updates are crucial for stakeholders to assess their investment strategies and expectations regarding future performance. The company remains committed to transparency and will continue to provide updates on its financial metrics.
MORE NEWS
July 20, 2026 - 02:56
From Banker to Broker: Why Lawry Miller Found His True Calling in Mortgage AdviceLawry Miller, the founder of Teachers and Nurses Mortgage & Finance, has spent years navigating the financial services industry. But unlike many advisers who drift into broking as a second career,...
July 19, 2026 - 05:24
India Probe Into Stolen Donations Tests Trust In Temple FinancesA widening investigation into allegedly stolen donations at India`s grand Ram temple in Ayodhya is raising fresh questions about how religious institutions handle the enormous sums of money and...
July 18, 2026 - 17:45
Analog Devices (ADI) at $375: Are Investors Paying an AI Premium for Industrial Tech?Analog Devices, Inc. (ADI) is trading at $375.18 as of July 16th, with a trailing price-to-earnings ratio of 56.63 and a forward P/E that raises questions about valuation. A bullish thesis on the...
July 18, 2026 - 10:04
‘ChatGPT for Doctors’ Mulls New Financing at $20 Billion ValuationOpenEvidence, the artificial intelligence startup that markets its chatbot as a `ChatGPT for doctors,` is considering a new round of financing that could value the company at roughly $20 billion....